Sunday, June 1, 2014

The Cost To Breathe

This week President Obama is expected to announce new EPA rules to regulate coal plants under EPA authority, and it's going to be the next war between Big Energy and those of us with lungs.  The GOP, bought and paid by these interests will stop at nothing to destroy the EPA totally.  But it turns out that the Clean Air Act, which gives the EPA authority over regulating the air we breathe, is actually saving America trillions of dollars -- yes, trillions with a "t" -- in health care expenses.



As a part of the 1990 amendments to the Clean Air Act, Congress required the EPA to conduct "periodic, scientifically reviewed studies to assess the benefits and the costs of the Clean Air Act." In other words, Congress wanted to know whether the Act "was worth it." The initial report in what is now a series was released in October 1997. The evaluation provided a detailed retrospective analysis of costs and benefits from the years 1970 to 1990 and showed that the overwhelming benefits obtained from compliance with the Act far outweighed the costs of implementation.

How much?

The EPA concluded that the total monetized health benefits from the Act during the 20-year period ranged between $5.6 and $49.4 trillion. The central estimate for benefits was $22.2 trillion. During that period, the costs to comply with the act were estimated to be approximately $0.5 trillion. Thus the net direct benefits were between $5.1 and $48.9 trillion, with a central estimate of $21.7 trillion. The benefit-cost rations were 43.4:1 for the central estimate and 11:1 and 97.8:1 for the extreme estimates. Who among us has an investment that has performed this well?

The second prospective EPA cost-benefit analysis was released in March 2011. The results of this study reflect the vast improvements in our understanding of the effects of particulate matter on the risk of premature death. These improvements are a direct result of the publication of large epidemiological studies and emphasize the importance of continuing research in this area. In addition the second prospective report adds several endpoints such as changes in visibility due to improved air quality, a better understanding of the relationship between peaks in fine particle concentrations and acute myocardial infarcts, and better mathematical modeling of air quality. Any way one may choose to interpret these data, benefits consistently outweigh costs by very large margins.

The projected benefits are attributed primarily to reductions in the concentrations of ground-level ozone and fine particles. The EPA estimates that in 2020 the Clean Air Act amendments will result in a 17 percent reduction in the direct emissions of small particles, or a reduction from 6,368 to 5,297 tons. While reductions in the emission of these primary particulates are a positive development, the most significant reductions in the total concentration of fine particles are attributed to reducing sulfur dioxide emissions.

Reductions in premature deaths are the most important source of the monetized benefits associated with the Clean Air Act amendments. By the year 2020 the scenario predicted by the amended Act avoids 230,000 premature deaths among adults age 30 and above each year. The model also predicts avoiding the deaths of 280 infants each year. The monetary value of these two causes was set at $1.7 trillion for adults and $2.5 billion for infants. Reductions in the number of cases of bronchitis, asthma, myocardial infarction, and other health effects contribute to the predicted $2 trillion in annual benefits by the end of this decade.

Yeah.  Trillions of dollars and hundreds of thousands of lives each year,  Thanks to the government.

Now think about what Republicans want to do to the Clean Air Act and the EPA.

No comments:

Post a Comment